Completed PHASE4 INTERVENTIONAL 5-arm NCT01633216

Poliovirus Vaccine Trial in Bangladesh

Assessment of the Immunogenicity of Three Doses of Bivalent, Trivalent or Type One Monovalent Oral Poliovirus Vaccines Provided at 2 or 4 Week Intervals

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh

Conditions Healthy Infants

Interventions Bivalent OPV 2 week interval Bivalent OPV 4 week interval Monovalent OPV 2 week interval Monovalent OPV 4 week interval Trivalent OPV 4 week interval

Updated 5 times since 2017 Last updated: Jan 6, 2013 Started: May 31, 2012 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Healthy Infants, this trial is completed. The trial is conducted by International Centre for Diarrhoeal Disease Research, Bangladesh and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

International Centre for Diarrhoeal Disease Research, Bangladesh

Data source: International Centre for Diarrhoeal Disease Research, Bangladesh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dhaka, Bangladesh
• Matlab, Bangladesh